Prolotherapy in the management of temporomandibular joint disorders

Authors

  • Esha Chowdhury Final Year Post graduate, Department of oral and Maxillofacial surgery, Sree Balaji Dental College and Hospital Bharath Institute of Higher Education and Research
  • Vijay Ebenezer Prof & Head, Department of oral and Maxillofacial surgery, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research.
  • Thulasi Ram E Reader, Department of Orthodontics, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research.
  • Mymoonah Risha S Senior Resident, Department of Microbiology, Sree Balaji Medical College and Hospital, Bharath Institute of Higher Education and Research.
  • Prabhu Manickam Natarajan Department of Clinical Sciences, Center of Medical and Bio-allied Health Sciences and Research, Ajman University, United Arab Emirates.

DOI:

https://doi.org/10.3329/bjms.v24i10.79192

Keywords:

dextrose, proliferant solution, prolotherapy, temporomandibular disorders, temporomandibular joint pain

Abstract

Discomfort and dysfunction in the jaw joint and its surrounding tissues are hallmarks of a complex set of disorders known as temporomandibular disorders (TMD). A newer method for treating TMD is prolotherapy, which is a kind of regenerative injectable treatment. A proliferant fluid, often dextrose, is injected into the joint area to induce a localised inflammatory response. This reduces temporomandibular joint discomfort while also encouraging tissue healing. When alternative treatment options for temporomandibular disorders (TMDs) have failed, prolotherapy may be a lifesaver. The regenerative nature of prolotherapy aligns with the need for interventions that address the underlying causes of TMD, such as joint laxity and ligamentous instability. For a successful outcome of prolotherapy, there must be a proper selection of patients and identification of specific subtypes of TMD. This article provides an overview of the different temporomandibular disorders and the application of prolotherapy in these disorders, summarizes existing evidence and highlights the key findings.

BJMS, Volume: 24. Supplementary Issue 2025, Page : 156-159

Downloads

Abstract
226
PDF
187

Downloads

Published

2025-02-11

How to Cite

Chowdhury , E., Ebenezer, V., Ram E, T., Risha S, M., & Natarajan, P. M. (2025). Prolotherapy in the management of temporomandibular joint disorders. Bangladesh Journal of Medical Science, 24(10), 156–159. https://doi.org/10.3329/bjms.v24i10.79192

Issue

Vol: 24. Supplementary issue 2025

Section

Original Articles

License

Copyright (c) 2025 Esha Chowdhury , Vijay Ebenezer, Thulasi Ram E, Mymoonah Risha. S, Prabhu Manickam Natarajan

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.